Next Generation Home Vision Assessment
NGHVA
4 other identifiers
observational
206
1 country
4
Brief Summary
Comparison of live remote paediatric digital vision testing outcomes versus face to face appointments in orthoptic clinic
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2023
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedFirst Submitted
Initial submission to the registry
May 20, 2024
CompletedFirst Posted
Study publicly available on registry
May 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJuly 18, 2025
July 1, 2025
1.5 years
May 20, 2024
July 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Acuity
Home versus Remote Acuity difference
2 weeks
Secondary Outcomes (2)
Colour Vision
2 weeks
Visual field
2 weeks
Study Arms (2)
Ibis
Tested with Ibis technology
Optonet
Tested with Optonet Technology
Interventions
Eligibility Criteria
Patients attending hospital and at home
You may qualify if:
- \- Patients attending hospital eye services will be eligible for enrolment.
- Age: less than 90 years old English speakers, as no available resource for translation services. Parents / patients must be able to provide consent Patient must be able to communicate what he / she sees on a vision assessment chart.
- Must have access to smartphone, tablet or home computer that can run video conferencing platforms.
You may not qualify if:
- Non English speakers or lack of ability to consent Inability to communicate what is seen on a chart, or inability to complete a preferential looking visual acuity test Inability to connect to a video conferencing platform.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- NHS Forth Valleylead
- Birmingham Children's Hospitalcollaborator
- NHS Fifecollaborator
- NHS Highlandcollaborator
Study Sites (4)
Birmingham Womens and Childens Hospital
Birmingham, Birmingham, B4 6NH, United Kingdom
NHS Fife
Inverness, Inverness, IV2 3JH, United Kingdom
NHS Forth Valley Research & Development Office
Falkirk, Stirlingshire, FK1 5SU, United Kingdom
NHS Greater Glasgow & Clyde
Glasgow, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Iain Livingstone, MBChB MD
NHS Forth Valley
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 20, 2024
First Posted
May 24, 2024
Study Start
March 1, 2023
Primary Completion
August 31, 2024
Study Completion
December 31, 2024
Last Updated
July 18, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Aim: 12 months post completion of study
- Access Criteria
- Open Access
Anonymised data will be made available as part of publication